CellType
CellType is a YC Winter 2026 (W26) company. Based in New York City, NY, USA. Team of 2.
About CellType
Summary
CellType builds AI agents that run the full drug discovery pipeline, using biological foundation models to simulate human biology. The technology, developed with Google DeepMind, replaces wet-lab-first discovery workflows by computationally identifying and validating treatment candidates. CellType targets large pharmaceutical companies, with Top 10 pharma already among its partners.
Go-to-market
Top 10 pharma companies are the primary customers, engaged through direct partnerships rather than self-serve channels.
From the Y Combinator listing
The agentic drug company. We simulate human biology.
CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We’re working with Top 10 pharma.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- New York City, NY, USA
- 2
- Active
- Early
Founders (2)
- Ivan Vrkic
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works